Home » Topics » BioWorld Science

BioWorld Science
RSS

Mesothelin-targeting CAR MCY-M11 appears to be safe in phase I trial

June 2, 2020

FDA approves Brilinta to reduce first heart attack in patients with coronary artery disease

June 2, 2020

Avelumab does not show activity in recurrent osteosarcoma trial

June 2, 2020

Interim phase Ib data with ALRN-6924 show chemoprotective effect

June 2, 2020

Ocugen discontinues phase III trial of OCU-300 for ocular graft-versus-host disease

June 2, 2020

FDA clears Opko to begin phase II trial of Rayaldee for mild to moderate COVID-19

June 2, 2020

Gilead reports phase III data on remdesivir in moderate COVID-19 pneumonia

June 2, 2020

Novus reports topline phase IIa data on OP-0201 in acute otitis media

June 2, 2020

Genentech and Roche synthesize new RAS protein inhibitors

June 2, 2020

New histone deacetylase inhibitors discovered at Merck & Co.

June 2, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...